4. 2) Farmakokinetikken for hydrochlorthiazid er ikke væsentligt anderledes hos patienter med levercirrhose.
Patients with liver impairment (see section 4.2) In patients with hepatic cirrhosis the pharmacokinetics of hydrochlorothiazide has not changed significantly.